先天性膈疝补片修补的系统综述
本系统综述检索 Embase、Medline、Scopus 和 Web of Science,纳入 63 篇文献、4595 例患者,其中 1803 例(39.2%)使用 19 种补片修补。补片修补总体复发率为 16.6%(n=299);在样本量 n>20 的补片中,GTX/Marlex 复发率最低(3.6%),按材料组 SNOR 复发率最低(14.0%),NSR 全部复发(100%)。
要点
- 4595 例先天性膈疝患者中 1803 例(39.2%)使用补片修补,共涉及 19 种补片类型。
- 补片修补总体复发率为 16.6%(n=299);样本量 n>20 的补片中 GTX/Marlex 复发率最低(3.6%)。
- 按材料组,SNOR 复发率最低(14.0%),NSR 复发率 100%,NR 为 31.5%,NSNOR 为 17.5%。
核心结论
- 在本队列中,超过三分之一的先天性膈疝使用补片关闭,迄今已有 19 种补片类型/变体用于先天性膈疝关闭。
- GTX 是最常用的补片,用于超过 60% 的患者;排除较小队列(n<20)后,GTX/Marlex 与最低复发率相关(3.6%)。
- SNOR 是与复发关联最少的材料类型,而 NSR 在所有病例中均出现复发。
研究设计与样本
- 系统综述,检索 Embase、Medline、Scopus 和 Web of Science。
- 纳入明确报告补片修补、所用材料及先天性膈疝修补后复发的文献。
- 共纳入 63 篇论文,呈现 4595 例患者的数据。
主要发现
- 4595 例患者中 1803 例(39.2%)使用 19 种补片管理。
- GTX(n=1106)是最常用的补片,其次为 Dualmesh(n=267)、Surgisis(n=156)、Marlex/GTX(n=56)、Tutoplast dura(n=40)、Dacron(n=34)、Dacron/GTX(n=32)、Permacol(n=24)、Teflon(n=24)、Surgisis/GTX(n=15)、Sauvage Filamentous Fabric(n=13)、Marlex(n=9)、Alloderm(n=8)、Silastic(n=4)、胶原包覆 Vicryl 补片(CCVM)(n=1)、Mersilene(n=1)和 MatriStem(n=1)。
- 生物材料进一步亚组为:合成不可吸收(SNOR)(n=1458)、天然可吸收(NR)(n=241)、天然与合成不可吸收复合(NSNOR)(n=103)、天然与合成可吸收复合(NSR)(n=1)。
- 补片修补总体复发率为 16.6%(n=299)。
- 对于 n>20 的补片类型,复发率最低为 GTX/Marlex(3.6%),其次为 Teflon(4.2%)、Dacron(5.6%)、Dualmesh(12.4%)、GTX(14.8%)、Permacol(16.0%)、Tutoplast Dura(17.5%)、SIS/GTX(26.7%)、SIS(34.6%)和 Dacron/GTX(37.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This systematic review aims to evaluate current choices in practice and outcomes of biomaterials used in patch repair of congenital diaphragmatic hernia (CDH). BACKGROUND: Multiple biomaterials, both novel and combinations of pre-existing materials are employed in patch repair of large size CDHs. METHODS: A literature search was performed across Embase, Medline, Scopus, and Web of Science. Publications that explicitly reported patch repair, material used, and recurrences following CDH repair were selected. RESULTS: Sixty-three papers were included, presenting data on 4595 patients, of which 1803 (39.2%) were managed using 19 types of patches. Goretex® (GTX) (n=1106) was the most frequently employed patch followed by Dualmesh® (n=267), Surgisis® (n=156), Marlex®/GTX® (n=56), Tutoplast dura® (n=40), Dacron® (n=34), Dacron®/GTX® (n=32), Permacol® (n=24), Teflon® (n=24), Surgisis®/GTX® (n=15), Sauvage® Filamentous Fabric (n=13), Marlex® (n=9), Alloderm® (n=8), Silastic® (n=4), Collagen coated Vicryl® mesh (CCVM) (n=1), Mersilene® (n=1), and MatriStem® (n=1) Biomaterials were further subgrouped as: synthetic nonresorbable (SNOR) (n=1458), natural resorbable (NR) (n=241), combined natural and synthetic nonresorbable (NSNOR) (n=103), and combined natural and synthetic resorbable (NSR) (n=1). The overall recurrence rate for patch repair was 16.6% (n=299). For patch types with n>20, recurrence rate was lowest in GTX/Marlex (3.6%), followed by Teflon (4.2%), Dacron (5.6%), Dualmesh (12.4%), GTX (14.8%), Permacol (16.0%), Tutoplast Dura (17.5%), SIS/GTX (26.7%), SIS (34.6%), and Dacron/GTX (37.5%).When analyzed by biomaterial groups, recurrence was highest in NSR (100%), followed by NR (31.5%), NSNOR (17.5%), and SNOR the least (14.0%). CONCLUSION: In this cohort, over one-third of CDH were closed using patches. To date, 19 patch types/variations have been employed for CDH closure. GTX is the most popular, employed in over 60% of patients; however, excluding smaller cohorts (n<20), GTX/Marlex is associated with the lowest recurrence rate (3.6%). SNOR was the material type least associated with recurrence, while NSR experienced recurrence in every instance.
引用
- Saxena AK, Hayward RK. Patches in Congenital Diaphragmatic Hernia: Systematic Review. Ann Surg. 2024. PMID: 38450531. doi:10.1097/SLA.0000000000006256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。